Jun. 22, 2022
US Supreme Court denies Bayer’s appeal of $25M Roundup verdict
“The company believes that the decision undermines the ability of companies to rely on official actions taken by expert regulatory agencies, as it permits every U.S. state to require a different product label, which conflicts with the clear intent of the ‘uniformity clause’ adopted by the U.S. Congress in FIFRA and similar statutes,” Bayer said in a statement.
The U.S. Supreme Court on Tuesday denied Bayer AG’s appeal of plaintiff Edwin Hardeman’s $25 million jury verdict that found his non-Hodgkin’s lymphoma was caused by the weedkiller Roundup.
The ruling is more bad news for Bayer in the weedkiller litigation.
On Friday, a 9th U.S. Circuit Court of Appeals vacated the EPA’s interim decision concluding that glyphosate, the key ingredient in Roundup, is not likely to...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In